Developed by the Ingersoll Rand business unit, the system integrates directly with existing containment technologies, including the DoverPac® and D100 lines. By shifting from manual handling to a semi-automatic interface, the technology allows a single operator to manage connection, transfer, and disconnection cycles. This approach minimizes the potential for process contamination and significantly lowers the volume of retained powder during manufacturing sequences.
Ciro Ahumada, Vice President and General Manager of Biopharma & Pharma Solutions, noted that the industry is pivoting toward integrated ecosystems that link storage, transfer, and processing stages. The DoverDoQ™ platform is built to work with liners from various suppliers, offering flexibility in hazardous environments where containment performance must be validated and measurable. The system is currently available for deployment across global pharmaceutical and chemical manufacturing sites.




Comments (0)
No comments yet. Be the first!